Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Material AgreementItem 1.01 · 8-KMEDIUM RiskNeutral

Medifast, Inc.

www.optavia.com
Filed: Mar 19, 2026Baltimore, MarylandCIK: 0000910329Health Care
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Medifast, Inc. entered into a Cooperation Agreement with Steamboat Capital Partners LLC on March 19, 2026, agreeing to nominate seven individuals including Daniel R. Chard and Elizabeth A. Geary to the Board of Directors at the 2026 Annual Meeting of Stockholders, representing a significant governance change.

Key Takeaways

Medifast agreed to nominate seven board members under a cooperation agreement with activist investor Steamboat Capital Partners

Named nominees include Daniel R. Chard and Elizabeth A. Geary, indicating potential strategic direction changes

2 more takeaways

Related Filings (1)

1 more filing from Medifast, Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateMar 19, 2026
Item1.01
CategoryMaterial Agreement
CIK0000910329
Accession #med-20260319
Risk LevelMEDIUM
SentimentNeutral
Signalinformational
Topics
board changematerial agreement

What This Means

The company entered into a significant agreement that could materially affect its business. This often signals new partnerships, licensing deals, or major contracts.
View Full Filing on SEC.govBrowse More Filings